Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2022-10-17 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
第四届董事会第四十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting, including decisions related to extending the validity of a non-public stock issuance resolution and authorizations, as well as the proposal to convene an extraordinary general meeting. It contains no financial statements or detailed financial data. The content focuses on board meeting decisions and upcoming shareholder meeting notices. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or financial statement, so it is not an Annual Report or Interim Report. It is not a voting result announcement (DVA) because it reports board resolutions, not shareholder vote results. Hence, the classification is MANG with high confidence.
2022-10-17 Chinese
关于控股股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder of the company. It details the number of shares released from pledge, the dates, and the shareholders involved. There is no financial report, earnings data, or management discussion. The content focuses on share pledge status and shareholder information, which fits the category of Major Shareholding Notification (MRQ). The document length is short and it is not a report publication or certification. Therefore, the classification is MRQ with high confidence.
2022-10-17 Chinese
关于环泊酚注射液新适应症上市申请获得批准的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement from 海思科医药集团股份有限公司 regarding the approval of a new indication for a pharmaceutical product (环泊酚注射液) by the National Medical Products Administration (国家药品监督管理局). It details the drug registration certificate, the new approved indication, and some product information. The document is relatively short (1110 characters) and is an announcement of regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it does not mention the release of a report but rather a regulatory approval announcement. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about product approval and related risks.
2022-10-17 Chinese
关于召开2022年第一次临时股东大会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the company's 2022 first extraordinary general meeting of shareholders (临时股东大会). It includes information about the meeting date, voting procedures, proposals to be voted on, registration details, and proxy forms. There is no financial data or report content, but rather a notice and instructions related to the shareholder meeting. The document length is 3813 characters, which is relatively short and consistent with an announcement rather than a full report. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-10-17 Chinese
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder of the company. It details the number of shares pledged, the proportion of total shares, pledge start and end dates, and the pledgees. There is no financial data, earnings information, or report content. The document is a regulatory announcement about share pledging, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like share issue, director dealings, or capital updates. The document length is short and it is an announcement rather than a report.
2022-10-14 Chinese
关于对控股公司提供财务资助的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding financial assistance provided by the company to its holding company. It details the amounts lent, agreements signed, and risk control measures. The document is relatively short (1338 characters) and focuses on an update about financing activities rather than a full financial report or audit. It does not contain financial statements or comprehensive financial data. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-09-29 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.